The value of screening HIV-infected individuals for didanosine-related liver disease?

Antiviral Therapy

Volumn 16, Issue 6, 2011, Pages 941-942

  Scourfield, Andrew ^a   Jackson, Akil ^a   Waters, Laura ^a   Gazzard, Brian ^a   Nelson, Mark ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; DIDANOSINE; HEMOGLOBIN;

ASCITES; BRAIN DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG EXPOSURE; ECHOGRAPHY; ELASTOGRAPHY; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; NONCIRRHOTIC PORTAL HYPERTENSION; PORTAL HYPERTENSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH DISEASE; THROMBOCYTE COUNT;

ANTI-HIV AGENTS; DIDANOSINE; HIV INFECTIONS; HUMANS; LIVER DISEASES; MASS SCREENING;

EID: 80052924190     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1875     Document Type: Letter

References (6)

1. Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007; 102:2536-2540. (Pubitemid 47631766)
2. Mallet V, Blanchard P, Verkarre V, et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21:187-192. (Pubitemid 46036926)
3. Saifee S, Joelson D, Braude J, et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol 2008; 6:1167-1169.
4. Maida I, Garcia-Gasco P, Sotgiu G, et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther 2008; 13:103-107. (Pubitemid 351541679)
5. Kovari H, Ledergerber B, Peter U, et al. Swiss HIV Cohort Study. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 2009; 49:626-635.
6. Merchante N, Pérez-Camacho I, Mira JA, et al. Prevalence and risk factors for abnormal liver stiffness in HIVinfected patients without viral hepatitis coinfection: role of didanosine. Antivir Ther 2010; 15:753-763.